Related Experiment Video

Updated: Jul 15, 2026

Preparation of 3D Fibrin Scaffolds for Stem Cell Culture Applications
07:04

Preparation of 3D Fibrin Scaffolds for Stem Cell Culture Applications

Published on: March 2, 2012

Fibrinogen and fibrin: scaffold proteins in hemostasis

Susan T Lord1

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. stl@med.unc.edu

Current Opinion in Hematology
|April 7, 2007
PubMed

Insights

This review details molecular mechanisms controlling fibrin clot structure and function. Understanding these processes is key to developing new therapies for cardiovascular disease and thrombosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biophysics

Background:

  • Elevated fibrinogen levels are a known cardiovascular risk factor.
  • Abnormal fibrin clot structure, strength, and stability are linked to coronary artery disease.
  • Understanding fibrin clot formation is crucial for cardiovascular health.

Purpose of the Study:

  • To define the molecular mechanisms controlling fibrin clot architecture and function in vivo.
  • To elucidate how molecular interactions influence clot properties.
  • To provide a basis for clinical and pharmaceutical studies.

Main Methods:

  • In-vitro experiments were conducted to investigate fibrin clot formation.
  • Biochemical and structural data were analyzed to understand monomer interactions.
  • Mechanical properties of fibrinogen and fibrin were measured.

Main Results:

  • 'A: a' interactions are primary in fibrin fiber formation, with 'B: b' interactions playing a minor role.
  • Specific molecular components (N-terminus of Bbeta, C-terminus of Aalpha, gamma' variant) modulate clot structure.
  • Fibrin fibers exhibit exceptional mechanical strength.
  • Fibrinogen-binding proteins influencing clot properties were identified.

Conclusions:

  • Mechanisms controlling fibrin clot structure, strength, and stability have been defined.
  • This knowledge can guide clinical studies on pathologic thrombosis.
  • Novel techniques for examining fibrin at molecular and fiber levels were established.
Abstract

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...